Of interest, PRKG1 is a novel negative regulator of osteoblast differentiation in human skeletal stem cells, and PRKG1 was found to have increased expression in idiopathic scoliosis, where it may become a therapeutic target [36,37]. Here, PRKG1 is linked to idiopathic scoliosis.